- Home
- MRVI vs VACH Comparison
MRVI vs VACH Comparison
Compare MRVI & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- VACH
- Stock Information
- Founded
- MRVI 2014
- VACH 2023
- Country
- MRVI United States
- VACH United States
- Employees
- MRVI N/A
- VACH N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- VACH
- Sector
- MRVI Health Care
- VACH
- Exchange
- MRVI Nasdaq
- VACH NYSE
- Market Cap
- MRVI 312.4M
- VACH 324.2M
- IPO Year
- MRVI 2020
- VACH 2024
- Fundamental
- Price
- MRVI $2.27
- VACH $10.39
- Analyst Decision
- MRVI Hold
- VACH
- Analyst Count
- MRVI 10
- VACH 0
- Target Price
- MRVI $6.84
- VACH N/A
- AVG Volume (30 Days)
- MRVI 1.6M
- VACH 108.0K
- Earning Date
- MRVI 08-06-2025
- VACH 01-01-0001
- Dividend Yield
- MRVI N/A
- VACH N/A
- EPS Growth
- MRVI N/A
- VACH N/A
- EPS
- MRVI N/A
- VACH 0.30
- Revenue
- MRVI $241,856,000.00
- VACH N/A
- Revenue This Year
- MRVI N/A
- VACH N/A
- Revenue Next Year
- MRVI $10.62
- VACH N/A
- P/E Ratio
- MRVI N/A
- VACH $35.15
- Revenue Growth
- MRVI N/A
- VACH N/A
- 52 Week Low
- MRVI $1.67
- VACH $9.95
- 52 Week High
- MRVI $10.03
- VACH $11.20
- Technical
- Relative Strength Index (RSI)
- MRVI 54.46
- VACH N/A
- Support Level
- MRVI $2.00
- VACH N/A
- Resistance Level
- MRVI $2.44
- VACH N/A
- Average True Range (ATR)
- MRVI 0.15
- VACH 0.00
- MACD
- MRVI -0.00
- VACH 0.00
- Stochastic Oscillator
- MRVI 61.36
- VACH 0.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.